Home Africa News Downtown Office Market Notches Slight Improvement Despite Tariff Threats

Downtown Office Market Notches Slight Improvement Despite Tariff Threats

Share
downtown-office-market-notches-slight-improvement-despite-tariff-threats
Downtown Office Market Notches Slight Improvement Despite Tariff Threats
Share

A new report shows Canada’s downtown office vacancy rate marked its first, if slight, improvement since the start of the pandemic.

The CBRE Group Inc. report shows the national downtown office vacancy rate dipped to 19.9 percent in the first quarter after hitting a record high of 20 percent in the previous quarter.

The report says both Toronto and Vancouver saw declining vacancy rates despite the overhang of tariffs, but that the overall market remains in limbo and the effects of trade tensions will become more clear next quarter.

New supply coming onto the market has been helping push vacancy rates up in recent years, but the first quarter was a rare one when no new supply was added downtown while some 400,000 square feet were taken off the market for conversion or demolition.

The combined downtown and suburban office vacancy rate, which has been bouncing around a narrow range in recent quarters, stood unchanged from the previous quarter at 18.7 percent.

CBRE says the industrial real estate market is likely to be more hit by tariffs, but that in the first quarter it still showed relatively solid net absorption.

Related Stories

US Office Vacancy Rate Hits Highest in Over 3 Decades: Moody’s
California Bill Aims to Fast Track Office-to-Housing Conversions in Downtown Areas
Share
Related Articles
iceland-focuses-on-security-partnerships-after-voters-reject-opening-eu-membership-talks
China NewsEuropeGlobalWorld News

Iceland Focuses on Security Partnerships After Voters Reject Opening EU Membership Talks

Icelandic Minister for Foreign Affairs Thorgerdur Katrin Gunnarsdottir attends a press conference...

vaccine-maker-halts-trial-on-mrna-cancer-shot
China NewsEuropeGlobalWorld News

Vaccine Maker Halts Trial on mRNA Cancer Shot

A pharmacist administers the Pfizer-BioNTech vaccine in Los Angeles, Calif., on October...